HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis

Virology Journal

Volumn 14, Issue 1, 2017, Pages 1-6

  Caselli, Elisabetta ^a   D'Accolti, Maria ^a   Soffritti, Irene ^a   Zatelli, Maria Chiara ^a   Rossi, Roberta ^b   Degli Uberti, Ettore ^a   Di Luca, Dario ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Autoimmune thyroiditis; HHV 6; miRNA

Indexed keywords

MICRORNA; MICRORNA 1238; MICRORNA 1238 2; MICRORNA 130A; MICRORNA 143 1; MICRORNA 155 2; MICRORNA 16 1; MICRORNA 202; MICRORNA 301B; MICRORNA 302C; MICRORNA 34A; MICRORNA 449B; MICRORNA 451 1; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IN VITRO STUDY; NONHUMAN; T LYMPHOCYTE; THYROID FOLLICULAR CELL; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; HUMAN HERPESVIRUS 7; MICROARRAY ANALYSIS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY;

GENE EXPRESSION PROFILING; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; THYROID EPITHELIAL CELLS; THYROIDITIS, AUTOIMMUNE;

EID: 85009100502     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-016-0672-6     Document Type: Article

References (23)

1. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42:252-65.
2. Thomas D, Liakos V, Michou V, Kapranos N, Kaltsas G, Tsilivakos V, Tsatsoulis A. Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease. Exp Clin Endocrinol Diabetes. 2008;116:35-9.
3. Caselli E, Zatelli MC, Rizzo R, Benedetti S, Martorelli D, Trasforini G, Cassai E, Degli Uberti EC, Di Luca D, Dolcetti R. Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLoS Pathog. 2012;8:e1002951.
4. Rizzo R, Zatelli MC, Rotola A, Cassai E, Degli Uberti E, Di Luca D, Caselli E: Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection. Adv Exp Med Biol. 2015;897:113-20.
5. Caselli E, Di Luca D. Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol. 2007;30:173-87.
6. Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, Flamand L, Frenkel N, Gallo R, Gompels UA, et al. Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol. 2014;159:863-70.
7. Tang H, Wang J, Mahmoud NF, Mori Y. Detailed study of the interaction between human herpesvirus 6B glycoprotein complex and its cellular receptor, human CD134. J Virol. 2014;88:10875-82.
8. Jasirwan C, Furusawa Y, Tang H, Maeki T, Mori Y. Human herpesvirus-6A gQ1 and gQ2 are critical for human CD46 usage. Microbiol Immunol. 2014;58:22-30.
9. Broccolo F, Fusetti L, Ceccherini-Nelli L. Possible role of human herpesvirus 6 as a trigger of autoimmune disease. Scientific World Journal. 2013;2013:867389.
10. Bernecker C, Lenz L, Ostapczuk MS, Schinner S, Willenberg H, Ehlers M, Vordenbaumen S, Feldkamp J, Schott M. MicroRNAs miR-146a1, miR-155_2, and miR-200a1 are regulated in autoimmune thyroid diseases. Thyroid. 2012;22:1294-5.
11. Yamada H, Itoh M, Hiratsuka I, Hashimoto S. Circulating microRNAs in autoimmune thyroid diseases. Clin Endocrinol (Oxf). 2014;81:276-81.
12. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles. Cell. 2009;136:26-36.
13. Caselli E, Bracci A, Galvan M, Boni M, Rotola A, Bergamini C, Cermelli C, Dal Monte P, Gompels UA, Cassai E, Di Luca D. Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication. Virology. 2006;346:402-14.
14. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9:839-45.
15. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316:608-11.
16. Sullivan RP, Fogel LA, Leong JW, Schneider SE, Wong R, Romee R, Thai TH, Sexl V, Matkovich SJ, Dorn 2nd GW, et al. MicroRNA-155 tunes both the threshold and extent of NK cell activation via targeting of multiple signaling pathways. J Immunol. 2013;191:5904-13.
17. Gracias DT, Stelekati E, Hope JL, Boesteanu AC, Doering TA, Norton J, Mueller YM, Fraietta JA, Wherry EJ, Turner M, Katsikis PD. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat Immunol. 2013;14:593-602.
18. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, Kahn ME, Rao DS, Baltimore D. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010;33:607-19.
19. Pekarsky Y, Croce CM. Role of miR-15/16 in CLL. Cell Death Differ. 2015;22:6-11.
20. Leong JW, Sullivan RP, Fehniger TA. microRNA management of NK-cell developmental and functional programs. Eur J Immunol. 2014;44:2862-8.
21. Jia X, Li X, Shen Y, Miao J, Liu H, Li G, Wang Z. MiR-16 regulates mouse peritoneal macrophage polarization and affects T-cell activation. J Cell Mol Med. 2016;20:1898-907.
22. Shi X, Zhan L, Xiao C, Lei Z, Yang H, Wang L, Zhao J, Zhang HT. miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer. Oncotarget. 2015;6:19043-54.
23. Glinsky GV. An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway. Cell Cycle. 2008;7:2570-83.